Identification of E-cadherin mutations in invasive lobular breast carcinoma (ILC).

被引：0
|
作者：
Droufakou, S
Deshmane, VH
Roylance, R
Hanby, AM
Sheer, D
Tomlinson, I
Hart, IR
机构：
[1] St Thomas Hosp, ICRF Lab, Richard Dimbleby Dept Canc Res, London, England
[2] Imperial Canc Res Fund, LIF 44, Human Cytogenet Lab, London, England
[3] Guys Hosp, Imperial Canc Res Fund, Breast Pathol Unit, London, England
[4] Imperial Canc Res Fund, LIF 44, Mol & Populat Genet Lab, London, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P26
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [21] Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast Cancer
    Alexander, John
    Mariani, Odette
    Meaudre, Celine
    Fuhrmann, Laetitia
    Xiao, Hui
    Naidoo, Kalnisha
    Gillespie, Andrea
    Roxanis, Ioannis
    Vincent-Salomon, Anne
    Haider, Syed
    Natrajan, Rachael
    CANCERS, 2022, 14 (02)
  • [22] E-cadherin in pleomorphic lobular carcinoma in situ and indeterminant carcinoma in-situ of breast
    Divine, G
    Linden, MD
    Raju, U
    Qureshi, HS
    MODERN PATHOLOGY, 2003, 16 (01) : 44A - 44A
  • [23] E-cadherin in pleomorphic lobular carcinoma in situ and indeterminant carcinoma in-situ of breast
    Qureshi, HS
    Divine, G
    Linden, MD
    Raju, U
    LABORATORY INVESTIGATION, 2003, 83 (01) : 44A - 44A
  • [24] E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis
    CB Vos
    AM Cleton-Jansen
    G Berx
    WJF de Leeuw
    NT ter Haar
    F van Roy
    CJ Cornelisse
    JL Peterse
    MJ van de Vijver
    British Journal of Cancer, 1997, 76 : 1131 - 1133
  • [25] Inactivation of E-cadherin and less sensitivity of lobular breast carcinoma cells to chemotherapy
    Altundag, Kadri
    Altundag, Ozden
    Akyurek, Serap
    Karakaya, Ebru
    Turen, Selahattin
    BREAST, 2006, 15 (03): : 300 - 300
  • [26] Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast
    Goldstein, NS
    Kestin, LL
    Vicini, FA
    CANCER, 2001, 92 (04) : 738 - 747
  • [27] E-cadherin (ECD) gene inactivation in pleomorphic lobular carcinoma (PLC) of the breast
    Palacios, J
    Garcia-Macias, MC
    Bryant, B
    Sobel, ME
    Merino, MJ
    MODERN PATHOLOGY, 2002, 15 (01) : 45A - 45A
  • [28] Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast
    Reis, FS
    Paredes, JC
    Milanezi, F
    Schmitt, FC
    CANCER, 2002, 94 (07) : 2114 - 2115
  • [29] Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
    Droufakou, S
    Deshmane, V
    Roylance, R
    Hanby, A
    Tomlinson, I
    Hart, IR
    INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (03) : 404 - 408
  • [30] E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis
    Vos, CBJ
    CletonJansen, AM
    Berx, G
    deLeeuw, WJF
    terHaar, NT
    vanRoy, F
    Cornelisse, CJ
    Peterse, JL
    vandeVijver, MJ
    BRITISH JOURNAL OF CANCER, 1997, 76 (09) : 1131 - 1133
12345